Judy Kirk

ORCID: 0000-0003-0390-2467
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • BRCA gene mutations in cancer
  • Genetic factors in colorectal cancer
  • Cancer Genomics and Diagnostics
  • Genomics and Rare Diseases
  • Nutrition, Genetics, and Disease
  • Family Support in Illness
  • Colorectal Cancer Screening and Detection
  • Childhood Cancer Survivors' Quality of Life
  • Global Cancer Incidence and Screening
  • Chronic Myeloid Leukemia Treatments
  • Dietetics, Nutrition, and Education
  • DNA Repair Mechanisms
  • Prenatal Screening and Diagnostics
  • Acute Lymphoblastic Leukemia research
  • Epigenetics and DNA Methylation
  • Climate Change Communication and Perception
  • Chronic Lymphocytic Leukemia Research
  • Patient-Provider Communication in Healthcare
  • PARP inhibition in cancer therapy
  • Cancer Risks and Factors
  • Ethics in Clinical Research
  • Cutaneous Melanoma Detection and Management
  • Genetic Associations and Epidemiology
  • Genomic variations and chromosomal abnormalities
  • Skin Protection and Aging

The University of Sydney
2014-2024

Westmead Hospital
2015-2024

Westmead Institute for Medical Research
2012-2024

Cancer Services
2006-2023

Hunter Genetics
2006-2023

Western Sydney University
2022

Westmead Institute
2000-2021

University of Rochester Medical Center
2002-2021

Cancer Australia
2008-2018

Unity Health System
2015-2017

Claire Vennin Pauline Mélénec Romain Rouet Max Nobis Aurélie Cazet and 95 more Kendelle J. Murphy David Herrmann Daniel A. Reed Morghan C. Lucas Sean Warren Zehra Elgundi Mark Pinese Gabriella Kalna Daniel Roden Monisha Samuel Anaiis Zaratzian Shane T. Grey Andrew Da Silva Wilfred Leung Amber L. Johns Lorraine A. Chantrill Angela Chou Angela Steinmann Mehreen Arshi Tanya Dwarte Danielle Froio Brooke A. Pereira Shona Ritchie Cecilia R Chambers Xanthe Metcalf Nicola Waddell John V. Pearson Ann-Marie Patch Katia Nones Felicity Newell Pamela Mukhopadhyay Venkateswar Addala Stephen H. Kazakoff Oliver Holmes Conrad Leonard Scott Wood Sean M. Grimmond Oliver Hofmann Angelika N. Christ Timothy J. C. Bruxner Jaswinder S. Samra Nick Pavlakis Hilda High Ray Asghari Neil D. Merrett Darren Pavey Amitabha Das Peter H. Cosman Kasim Ismail Chelsie O’Connnor Alina Stoita David M. Williams Allan Spigellman Vincent Lam Duncan McLeod Judy Kirk James G. Kench Peter Grimison Caroline Cooper Charbel Sandroussi Annabel Goodwin R. Scott Mead Katherine Tucker Lesley Andrews Michael Texler Cindy Forest Krishna Epari Mo Ballal David Fletcher Sanjay Mukhedkar Nikolajs Zeps Maria Beilin Kynan Feeney Nan Q. Nguyen Andrew Ruszkiewicz Chris Worthley John Chen Mark E. Brooke‐Smith Virginia Papangelis Andrew D. Clouston Andrew P. Barbour Thomas O’Rourke Jonathan W. Fawcett Kellee Slater Michael Hatzifotis Peter Hodgkinson Mehrdad Nikfarjam James R. Eshleman Ralph H. Hruban Christopher L. Wolfgang Rita T. Lawlor Stefania Beghelli Vincenzo Corbo Maria Scardoni Claudio Bassi

Abstract Heterogeneous subtypes of cancer-associated fibroblasts (CAFs) coexist within pancreatic cancer tissues and can both promote restrain disease progression. Here, we interrogate how cells harboring distinct alterations in p53 manipulate CAFs. We reveal the existence a p53-driven hierarchy, where with gain-of-function (GOF) mutant educate dominant population CAFs that establish pro-metastatic environment for GOF null alike. also demonstrate educated by may be reprogrammed either or...

10.1038/s41467-019-10968-6 article EN cc-by Nature Communications 2019-08-12

Clinicopathologic data from a population-based endometrial cancer cohort, unselected for age or family history, were analyzed to determine the optimal scheme identification of patients with germline mismatch repair (MMR) gene mutations.Endometrial cancers 702 recruited into Australian National Endometrial Cancer Study (ANECS) tested MMR protein expression using immunohistochemistry (IHC) and MLH1 promoter methylation in MLH1-deficient cases. mutation testing was performed on DNA MMR-protein...

10.1200/jco.2013.51.2129 article EN Journal of Clinical Oncology 2013-12-10
Jessica L. Chitty Michelle Yam Lara Perryman Amelia L. Parker Joanna N. Skhinas and 95 more Yordanos F. Setargew Ellie T. Y. Mok Emmi Tran Rhiannon D. Grant Sharissa L. Latham Brooke A. Pereira Shona Ritchie Kendelle J. Murphy Michael Trpceski Alison D. Findlay Pauline Mélénec Elysse C. Filipe Audrey Nadalini Sipiththa Velayuthar Gretel Major Kaitlin Wyllie Michael Papanicolaou Shivanjali Ratnaseelan Phoebe A. Phillips George Sharbeen Janet Youkhana Alice G. Russo Antonia Blackwell Jordan F. Hastings Morghan C. Lucas Cecilia R. Chambers Daniel A. Reed Janett Stoehr Claire Vennin Ruth Pidsley Anaiis Zaratzian Andrew M. Da Silva Michael Tayao Brett Charlton David Herrmann Max Nobis Susan J. Clark Andrew V. Biankin Amber L. Johns David R. Croucher Adnan Nagrial Anthony J. Gill Sean M. Grimmond Lorraine A. Chantrill Angela Chou Tanya Dwarte Xanthe L. Metcalf Gloria Jeong Lara Kenyon Nicola Waddell John V. Pearson Ann-Marie Patch Kátia Nones Felicity Newell Pamela Mukhopadhyay Venkateswar Addala Stephen H. Kazakoff Oliver Holmes Conrad Leonard Scott Wood Oliver Hofmann Jaswinder S. Samra Nick Pavlakis Jennifer Arena Hilda High Ray Asghari Neil D. Merrett Amitabha Das Peter H. Cosman Kasim Ismail Alina Stoita David B. Williams Allan Spigellman Duncan McLeo Judy Kirk James G. Kench Peter Grimison Charbel Sandroussi Annabel Goodwin R. Scott Mead Katherine L. Tucker Lesley Andrews Michael Texler Cindy Forrest Mo Ballal David Fletcher Maria Beilin Kynan Feeney Krishna Epari Sanjay Mukhedkar Nikolajs Zeps Nan Q. Nguyen Andrew Ruszkiewicz Chris Worthley John Chen

Abstract The lysyl oxidase family represents a promising target in stromal targeting of solid tumors due to the importance this crosslinking and stabilizing fibrillar collagens its known role tumor desmoplasia. Using small-molecule drug-design approaches, we generated validated PXS-5505, first-in-class highly selective potent pan-lysyl inhibitor. We demonstrate vitro vivo that inhibition decreases chemotherapy-induced pancreatic desmoplasia stiffness, reduces cancer cell invasion metastasis,...

10.1038/s43018-023-00614-y article EN cc-by Nature Cancer 2023-08-28

To determine the timing of pubertal development and frequency gonadal dysfunction in children who survive acute lymphoblastic leukemia, we assessed status plasma levels sex steroids, gonadotropin, inhibin 45 (20 girls 25 boys) had received combination chemotherapy along with 24 Gy irradiation to cranium (modified LSA2L2 protocol). We also reexamined testicular biopsy specimens, obtained at time cessation chemotherapy, for presence germ cells. Germ-cell damage, indicated by marked elevations...

10.1056/nejm198907203210303 article EN New England Journal of Medicine 1989-07-20

Pathogenic germline MAX variants are associated with pheochromocytoma and paraganglioma (PPGL), pituitary neuroendocrine tumors and, possibly, other endocrine nonendocrine tumors.To report 2 families variants, pheochromocytomas (PCs) multiple tumors.Clinical, genetic, immunohistochemical, functional studies at University hospitals in Australia on undergoing usual clinical care. The main outcome measures were phenotyping; tumor sequencing; immunohistochemistry of PC tumors; variants.Family A...

10.1210/clinem/dgaa957 article EN The Journal of Clinical Endocrinology & Metabolism 2020-12-24
Vanessa Lakis Rita T. Lawlor Felicity Newell Ann‐Marie Patch Andrea Mafficini and 95 more Anguraj Sadanandam Lambros T. Koufariotis Rebecca L. Johnston Conrad Leonard Scott Wood Borislav C. Rusev Vincenzo Corbo Claudio Luchini Sara Cingarlini Luca Landoni Roberto Salvia Michèle Milella David K. Chang Peter J. Bailey Nigel B. Jamieson Fraser R. Duthie Marie‐Claude Gingras Donna M. Muzny David A. Wheeler Richard A. Gibbs Massimo Milione Lorraine A. Chantrill Paul Timpson Angela Chou Marina Pajic Angela Murphy Tanya Dwarte David Hermann Claire Vennin Thomas R. Cox Brooke A. Pereira Shona Ritchie Daniel A. Reed Cecilia R. Chambers Xanthe L. Metcalf Max Nobis Pamela Mukhopadhyay Venkateswar Addala Stephen H. Kazakoff Oliver Holmes Qinying Xu Oliver Hofmann Jaswinder S. Samra Nick Pavlakis Jennifer Arena Hilda High Ray Asghari Neil D. Merrett Darren Pavey Amitabha Das Peter H. Cosman Kasim Ismail Chelsie O’Connnor Alina Stoita David B. Williams Allan Spigellman Vincent Lam Duncan McLeod Judy Kirk James G. Kench Peter Grimison Charbel Sandroussi Annabel Goodwin R. Scott Mead Katherine Tucker Lesley Andrews Michael Texler Cindy Forest Mo Ballal David Fletcher Nikolajs Zeps Nan Q. Nguyen Andrew Ruszkiewicz Chris Worthley John Chen Mark E. Brooke‐Smith Virginia Papangelis Andrew D. Clouston Andrew P. Barbour Thomas O’Rourke Jonathan W. Fawcett Kellee Slater Michael Hatzifotis Peter Hodgkinson Mehrdad Nikfarjam James R. Eshleman Ralph H. Hruban Christopher L. Wolfgang Judith Dixon Maria Scardoni Claudio Bassi Sonia Grimaldi Cinzia Cantù Giada Bonizzato Samantha Bersani

Here we report the DNA methylation profile of 84 sporadic pancreatic neuroendocrine tumors (PanNETs) with associated clinical and genomic information. We identified three subgroups PanNETs, termed T1, T2 T3, distinct patterns methylation. The T1 subgroup was enriched for functional ATRX, DAXX MEN1 wild-type genotypes. contained mutations in recurrent chromosomal losses half genome no association between regions loss levels. were larger had lower MGMT gene body, which showed positive...

10.1038/s42003-020-01469-0 article EN cc-by Communications Biology 2021-02-03

PURPOSE: To assess intention to undergo prophylactic bilateral mastectomy and psychologic determinants in unaffected women at increased risk of developing hereditary breast cancer. PATIENTS AND METHODS: Three hundred thirty-three who were awaiting their initial appointments for assessment, advice about surveillance, options one 14 familial cancer clinics participated a cross-sectional, questionnaire-based survey. RESULTS: Nineteen percent would consider 47% not mastectomy, should genetic...

10.1200/jco.2000.18.11.2250 article EN Journal of Clinical Oncology 2000-06-11

The incidence and clinical implications of unusual patterns expression leucocyte differentiation antigens in acute leukaemia were assessed on 568 newly diagnosed paediatric adult cases undergoing immunophenotyping with a panel monoclonal antibodies at single centre. Among patients the precursor B (common) form lymphoblastic (ALL), major variant seen was group 15 myeloid surface antigens. 4.5% ALL tested antibody to CD-11b positive, 5.1% CD-13+, 10.8% CD-33+. All achieved complete remission...

10.1111/j.1365-2141.1989.tb04315.x article EN British Journal of Haematology 1989-08-01

Background Microseminoprotein-beta (MSMB) regulates apoptosis and using genome-wide association studies the rs10993994 single nucleotide polymorphism in MSMB promoter has been linked to an increased risk of developing prostate cancer. The location allele, its ability reduce activity, suggested that allele could result lowered benign tissue leading cancer risk. Methodology/Principal Findings expression malignant was examined immunohistochemistry compared with genotype. Urinary concentrations...

10.1371/journal.pone.0013363 article EN cc-by PLoS ONE 2010-10-13

Telegenetics offers an alternative model of delivering genetic counseling to rural and outreach areas; however there is a dearth qualitative research into the patient's experience. Twelve women who had received telemedicine for hereditary breast and/or ovarian cancer (HBOC) within previous 12 months participated in semi-structured telephone interview. The interview explored women's experience with telegenetics, satisfaction, perceived advantages disadvantages quality interaction their...

10.1007/s10897-010-9301-5 article EN Journal of Genetic Counseling 2010-04-21

PurposeWe evaluated the impact of personal melanoma genomic risk information on sun-related behaviors and psychological outcomes.MethodsIn this parallel group, open, randomized controlled trial, 1,025 Australians European ancestry without aged 18–69 years were recruited via Medicare database (3% consent). Participants to intervention (n = 513; saliva sample for genetic testing, personalized booklet based a 40-variant polygenic score, telephone-based counseling, educational booklet) or...

10.1038/s41436-021-01292-w article EN cc-by Genetics in Medicine 2021-08-12
Cristina Fortuño Bing Feng Courtney Carroll Giovanni Innella Wendy Kohlmann and 95 more Conxi Lázaro Joan Brunet Lídia Feliubadaló Sílvia Iglesias Mireia Menéndez Àlex Teulé Mandy L. Ballinger David M. Thomas Ainsley Campbell Mike Field Marion Harris Judy Kirk Nicholas Pachter Nicola Poplawski Rachel Susman Kathy Tucker Mathew Wallis Rachel Williams Elisa J. Cops David E. Goldgar Paul A. James Amanda B. Spurdle David J. Amor Lesley Andrews Yoland Antill Rosemary L. Balleine Jonathan Beesley Ian Bennett Michael Bogwitz Simon Bodek Leon Botes Meagan Brennan Melissa A. Brown Michael F. Buckley Jo Burke Phyllis Butow Liz Caldon Ian Campbell Michelle Cao Anannya Chakrabarti Deepa Chauhan Manisha Chauhan Georgia Chenevix‐Trench Alice Christian Paul A. Cohen Alison Colley Ashley Crook James Cui Eliza Courtney Margaret C. Cummings Sarah‐Jane Dawson Anna deFazio Martin Delatycki Rebecca Dickson Joanne Dixon Ted Edkins Stacey L. Edwards Gelareh Farshid Andrew Fellows Georgina Fenton Michael Field James M. Flanagan Peter C.C. Fong Laura Forrest Stephen B. Fox Juliet D. French Michael Friedlander Clara Gaff Mike Gattas Peter George Sian Greening Marion Harris Stewart Hart Nicholas K. Hayward John L. Hopper Cass Hoskins Clare Hunt Paul A. James Mark A. Jenkins Alexa Kidd Judy Kirk Jessica Koehler James Kollias Sunil R. Lakhani Mitchell Lawrence Jason S. Lee Shuai Li Geoffrey J. Lindeman Jocelyn Lippey Lara Lipton Liz Lobb Sherene Loi Graham J. Mann Deborah J. Marsh Sue Anne McLachlan

PURPOSE Establishing accurate age-related penetrance figures for the broad range of cancer types that occur in individuals harboring a pathogenic germline variant TP53 gene is essential to determine most effective clinical management strategies. These also permit optimal use cosegregation data classification variants unknown significance. Penetrance estimation can easily be affected by bias from ascertainment criteria, an issue not commonly addressed previous studies. MATERIALS AND METHODS...

10.1200/po.23.00453 article EN JCO Precision Oncology 2024-02-01

The breast cancer susceptibility genes BRCA1 and BRCA2 are responsible for a large proportion of familial ovarian cancer, yet little is known how disruptions in the functions proteins these encode increased risk preferentially hormone-dependent tissue. There no information on whether germ-line mutation or causes hormone-signaling pathways normal breast. In this study markers hormone responsiveness were measured prophylactically removed tissue (n = 31) women bearing pathogenic one BRCA genes....

10.1002/gcc.10321 article EN Genes Chromosomes and Cancer 2004-01-08

Abstract Background: Communication of personalized melanoma genomic risk information may improve prevention behaviors. Methods: We evaluated the feasibility and acceptability communicating to public its preliminary impact on behaviors psychosocial outcomes. One hundred eighteen people aged 22 69 years provided a saliva sample were randomized control (nonpersonalized educational materials) or intervention (personalized booklet presenting as absolute relative risks category based variants in...

10.1158/1055-9965.epi-16-0395 article EN Cancer Epidemiology Biomarkers & Prevention 2016-10-05
Coming Soon ...